The European Adult Immunisation Hub is led by the International Longevity Centre – UK (ILC-UK). It has been made possible by financial support from Pfizer.
For regular updates, follow the European Adult Immunisation Hub on Twitter at @AImmunisation,
like the Hub’s Facebook page at https://www.facebook.com/adultimmunisation/timeline
and join the Adult Immunisation Linkedin group at https://www.linkedin.com/groups/8358969
A database of immunisation providers is available for the countries listed below. Please follow the link to be directed to the database:
New research published in the Journal of the American College of Cardiology finds an association between Shingles and cardiovascular events.
New research published by Marshall University and promoted by Science Daily, reveals that patients who recover from invasive pneumococcal pneumonia may suffer shorter longevity.
‘When the drugs won’t work: Antimicrobial resistance and the future of medicine’ outlines what governments, medical professionals and individuals can do to help prevent medicine being ‘plunged back into the dark ages’.
In May 2017, IFPMA brought together industry leaders, senior policymakers, and representations from the diplomatic community, as well as key global health stakeholders attending the World Health Assembly, to discuss immunisation and prevention.
New research has been published in Vaccine on pneumococcal disease in hospitals (Canada)
A report in the Daily Telegraph has revealed that a mismatch between the flu vaccine and the dominant strain of influenza may have contributed to increased mortality in 2016.